Skip to main content
MJHS
Navigation
Journal Navigation
Article Navigation
Epilepsy-specific quality-of-life questionnaires and social stigma scales in adults with epilepsy: a methodological review
Gabriela Lișinschi-Baranov1, Stanislav Groppa2, Larisa Spinei3, Vitalie Ojovan4,5, Vitalie Chiosa2, Alina Ferdohleb3,5*
https://doi.org/10.52645/MJHS.2026.2.10
Adult epilepsy generates a burden that extends beyond seizure counts and includes adverse treatment effects, role restriction, emotional distress, and the social devaluation attached to the diagnosis. The methodological problem is not the absence of patient-reported measures, but the heterogeneity with which disease-specific quality-of-life and stigma instruments are selected, interpreted, and combined in adult studies.
Impact of COVID-19 on chronic kidney disease progression: a prospective cohort study
Tatiana Răzlog1*, Eugeniu Russu1,2, Costina Groza1, Liliana Groppa2
https://doi.org/10.52645/MJHS.2026.2.04
Chronic kidney disease and COVID-19 are both associated with significant morbidity. Patients with chronic kidney disease are at risk for severe COVID-19, and SARS-CoV-2 infection may accelerate CKD progression. This study aimed to compare renal outcomes in CKD patients with and without prior COVID-19 and to identify predictors of progression.
Deep endometriosis – diagnosis and impact on quality of life
Elena Ivanova*, Nadejda Codreanu
https://doi.org/10.52645/MJHS.2024.2.03
Deep infiltrating endometriosis (DIE) is considered the most painful form of endometriosis, responsible for reducing the women's quality of life (QoL). Its management presents difficulties in medicine. The #Enzian classification reflects locations of DIE and simplifies its medical management. International guidelines recommend studies of QoL in women with endometriosis.